Investment
Features
FeesSafety
Academy
More
Pluang+

Wabtec raises 2026 outlook with strong earnings growth and backlog momentum, maintaining Buy rating.

Company Fundamentals
06 Oct 2026
Seeking Alpha
View Source
Bullish
Wabtec raises 2026 outlook with strong earnings growth and backlog momentum, maintaining Buy rating.

Wabtec Corporation has raised its fiscal year 2026 guidance, expecting adjusted EPS of $10.60–$10.90 and revenue between $12.3–$12.6 billion, targeting nearly 20% EPS growth. The company's growth is driven by recent acquisitions and international contracts, although these introduce integration and currency risks. Despite these risks, Wabtec maintains manageable debt levels with a stable BBB rating from Fitch. Shareholders benefit from ongoing share buybacks and dividend increases, though the dividend yield remains modest at 0.43%.

Wabtec's fiscal outlook and earnings growth are noted here with Pluang's Industrials sector data as context. As of Oct 06, 2026 18:13 WIB, 65 of 93 priced Industrials-sector US stocks on Pluang rose while 22 fell. Notable movers include SMR at USD 7.82 with a 1-day change of +1.82%, BWXT at USD 137.60 up +1.66%, and POWL at USD 201.00 up +1.60%.

More News

Costco shares drop 10% in 6 months while S&P 500 rises 17%, raising value questions below $900.

Costco shares drop 10% in 6 months while S&P 500 rises 17%, raising value questions below $900.

Over the past six months, Costco's stock has fallen by 10%, contrasting with the S&P 500's 17% gain. This decline has sparked debate on whether Costco's shares, now trading under $900, represent a buying opportunity. Investors are weighing if the pri...

Analyst Insights
Neutral
3 hours ago
IceCure Medical adds Legacy Health to U.S. study on cryoablation for low-risk breast cancer

IceCure Medical adds Legacy Health to U.S. study on cryoablation for low-risk breast cancer

IceCure Medical has expanded its U.S. clinical network for the ChoICE Study by adding Legacy Health in Oregon as a new site. The study evaluates the safety and effectiveness of ProSense® cryoablation, a minimally invasive treatment for low-risk breas...

Market News
Bullish
4 hours ago
Palantir's stock jumps 60% in Q3, its best quarter in over a year, but high valuation demands flawless growth.

Palantir's stock jumps 60% in Q3, its best quarter in over a year, but high valuation demands flawless growth.

Palantir Technologies saw its stock rise 60.3% in the third quarter, marking its strongest quarterly gain since mid-2025, driven by a 93% revenue increase to $1.935 billion and a 149% jump in U.S. commercial revenue. Despite this surge, Palantir is o...

Company Fundamentals
Bullish
4 hours ago
Nike shares hit worst year but long-term investors see buying opportunity amid turnaround hopes

Nike shares hit worst year but long-term investors see buying opportunity amid turnaround hopes

Nike shares are performing poorly this year, reflecting investor skepticism due to the company's struggling operating results. Despite the negative sentiment, analyst Justin Purohit believes that long-term investors could benefit from holding onto or...

Analyst Insights
Bullish
4 hours ago
Cardano price nears $0.28 resistance with rising leverage and whale activity amid new RealFi launch.

Cardano price nears $0.28 resistance with rising leverage and whale activity amid new RealFi launch.

Cardano's ADA price climbed to around $0.279, approaching the $0.28 resistance level after gaining nearly 9% in a week. The rally is supported by increased derivatives open interest and whale transactions, indicating new leveraged bets entering the m...

Technical Signals
Bullish
4 hours ago
banner-footerbanner-footer

Invest & Trade with
#1 Award-Winning Investment Super App